| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5684016 | PFIZER PHARMS | Method of treating cardiac insufficiency |
Nov, 2014
(9 years ago) | |
|
US5684016 (Pediatric) | PFIZER PHARMS | Method of treating cardiac insufficiency |
May, 2015
(9 years ago) | |
Accupril is owned by Pfizer Pharms.
Accupril contains Quinapril Hydrochloride.
Accupril has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Accupril are:
- US5684016
- US5684016*PED
Accupril was authorised for market use on 19 November, 1991.
Accupril is available in tablet;oral dosage forms.
Accupril can be used as method of treating congestive heart failure.
The generics of Accupril are possible to be released after 04 May, 2015.
Drugs and Companies using QUINAPRIL HYDROCHLORIDE ingredient
Market Authorisation Date: 19 November, 1991
Treatment: Method of treating congestive heart failure
Dosage: TABLET;ORAL
How can I launch a generic of ACCUPRIL before it's drug patent expiration?
More Information on Dosage
ACCUPRIL family patents
